Insider Transactions Reported by 21 Insiders of DiaMedica Therapeutics Inc.

Symbol
DMAC on Nasdaq
Location
Minneapolis, MN

Insiders trading volume in the past year

DiaMedica Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jan Stahlberg 10%+ Owner $75,679,855 +$18,989,576 +33% 17 Nov 2025
Thomas Von Koch 10%+ Owner $29,342,519 +$9,999,997 +52% 23 Jul 2025
Richard Jacinto II 10%+ Owner $17,355,880 +$1,400,000 +8.8% 23 Jul 2025
Randall Michael Giuffre Director $3,727,417 02 Jan 2026
David J. Wambeke Chief Business Officer $3,420,969 01 Jun 2025
Richard D. Pilnik Director $1,440,505 07 Apr 2025
Parsons James T. Director $824,730 02 Jan 2026
Dietrich John Pauls President & CEO, Director $445,155 01 Jun 2025
Charles Pauling Semba Director $403,848 02 Jan 2026
Scott Kellen CFO & Secretary $209,562 01 Jun 2025
Amy L. Burroughs Director $205,206 03 Jan 2023
Richard Kuntz Director $129,332 01 Jun 2025
HARRY W. ALCORN JR SVP, Clinical Operations $123,147 15 Sep 2021
Dominic R. Cundari Chief Commercial Officer $7,840 01 Jun 2024
Daniel J. O'Connor Director $0 20 Feb 2025
Tanya Lewis Director $0 01 Jun 2025
Julie Krop Chief Marketing Officer 11 Aug 2025
Sydney A. Gilman VP, Regulatory Affairs 28 Jul 2021
Kirsten L. Gruis Chief Medical Officer 01 Jun 2023
Julie VanOrsdel Daves SVP Clinical Development Oper. 01 Jun 2023
Masuoka K. Lorianne Chief Medical Officer 22 Jan 2024

Recent Insider Transactions by Companies or Individuals for DiaMedica Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.